nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine monophosphate—Cladribine—multiple sclerosis	0.442	1	CrCtD
Adenosine monophosphate—PIM1—Mitoxantrone—multiple sclerosis	0.202	1	CbGbCtD
Adenosine monophosphate—Regadenoson—Cladribine—multiple sclerosis	0.0432	0.161	CrCrCtD
Adenosine monophosphate—Clofarabine—Cladribine—multiple sclerosis	0.0432	0.161	CrCrCtD
Adenosine monophosphate—Fludarabine—Cladribine—multiple sclerosis	0.0406	0.151	CrCrCtD
Adenosine monophosphate—Nelarabine—Cladribine—multiple sclerosis	0.0382	0.142	CrCrCtD
Adenosine monophosphate—Adenosine—Cladribine—multiple sclerosis	0.0343	0.128	CrCrCtD
Adenosine monophosphate—Vidarabine—Cladribine—multiple sclerosis	0.0343	0.128	CrCrCtD
Adenosine monophosphate—Azacitidine—Cladribine—multiple sclerosis	0.0343	0.128	CrCrCtD
Adenosine monophosphate—CREB1—nerve—multiple sclerosis	0.00121	0.0358	CbGeAlD
Adenosine monophosphate—S-Adenosylmethionine—SRM—multiple sclerosis	0.00111	0.479	CrCbGaD
Adenosine monophosphate—ADCY1—brainstem—multiple sclerosis	0.000859	0.0253	CbGeAlD
Adenosine monophosphate—PYGL—retina—multiple sclerosis	0.000846	0.025	CbGeAlD
Adenosine monophosphate—ADCY1—retina—multiple sclerosis	0.000829	0.0245	CbGeAlD
Adenosine monophosphate—PYGL—Azacitidine—Cladribine—multiple sclerosis	0.000761	1	CbGdCrCtD
Adenosine monophosphate—PRKAB2—medulla oblongata—multiple sclerosis	0.000639	0.0189	CbGeAlD
Adenosine monophosphate—PRKAB2—midbrain—multiple sclerosis	0.000584	0.0172	CbGeAlD
Adenosine monophosphate—PRKAB1—retina—multiple sclerosis	0.000575	0.017	CbGeAlD
Adenosine monophosphate—PRKAB2—spinal cord—multiple sclerosis	0.00057	0.0168	CbGeAlD
Adenosine monophosphate—PYGL—spinal cord—multiple sclerosis	0.000545	0.0161	CbGeAlD
Adenosine monophosphate—CREB1—brainstem—multiple sclerosis	0.000521	0.0154	CbGeAlD
Adenosine monophosphate—CREB1—retina—multiple sclerosis	0.000502	0.0148	CbGeAlD
Adenosine monophosphate—HINT1—medulla oblongata—multiple sclerosis	0.000485	0.0143	CbGeAlD
Adenosine monophosphate—Clofarabine—RRM1—multiple sclerosis	0.000477	0.205	CrCbGaD
Adenosine monophosphate—Fludarabine—RRM1—multiple sclerosis	0.000462	0.199	CrCbGaD
Adenosine monophosphate—PRKAB2—cerebellum—multiple sclerosis	0.000452	0.0133	CbGeAlD
Adenosine monophosphate—ADCY1—nervous system—multiple sclerosis	0.00045	0.0133	CbGeAlD
Adenosine monophosphate—HINT1—midbrain—multiple sclerosis	0.000443	0.0131	CbGeAlD
Adenosine monophosphate—ADCY1—central nervous system—multiple sclerosis	0.000433	0.0128	CbGeAlD
Adenosine monophosphate—PYGL—cerebellum—multiple sclerosis	0.000432	0.0128	CbGeAlD
Adenosine monophosphate—HINT1—spinal cord—multiple sclerosis	0.000432	0.0127	CbGeAlD
Adenosine monophosphate—ADCY1—cerebellum—multiple sclerosis	0.000424	0.0125	CbGeAlD
Adenosine monophosphate—PRKAB1—medulla oblongata—multiple sclerosis	0.000415	0.0123	CbGeAlD
Adenosine monophosphate—ACSS1—medulla oblongata—multiple sclerosis	0.000403	0.0119	CbGeAlD
Adenosine monophosphate—PIM1—medulla oblongata—multiple sclerosis	0.000391	0.0115	CbGeAlD
Adenosine monophosphate—APRT—medulla oblongata—multiple sclerosis	0.000386	0.0114	CbGeAlD
Adenosine monophosphate—ACSS2—medulla oblongata—multiple sclerosis	0.000386	0.0114	CbGeAlD
Adenosine monophosphate—ACSL1—medulla oblongata—multiple sclerosis	0.000384	0.0113	CbGeAlD
Adenosine monophosphate—PRKAB1—spinal cord—multiple sclerosis	0.00037	0.0109	CbGeAlD
Adenosine monophosphate—ACSS1—midbrain—multiple sclerosis	0.000368	0.0109	CbGeAlD
Adenosine monophosphate—PRKAB2—brain—multiple sclerosis	0.000367	0.0108	CbGeAlD
Adenosine monophosphate—HINT1—nervous system—multiple sclerosis	0.000364	0.0107	CbGeAlD
Adenosine monophosphate—CREB1—medulla oblongata—multiple sclerosis	0.000363	0.0107	CbGeAlD
Adenosine monophosphate—ACSS1—spinal cord—multiple sclerosis	0.000359	0.0106	CbGeAlD
Adenosine monophosphate—PIM1—midbrain—multiple sclerosis	0.000358	0.0106	CbGeAlD
Adenosine monophosphate—SRC—retina—multiple sclerosis	0.000354	0.0104	CbGeAlD
Adenosine monophosphate—ACSS2—midbrain—multiple sclerosis	0.000353	0.0104	CbGeAlD
Adenosine monophosphate—APRT—midbrain—multiple sclerosis	0.000353	0.0104	CbGeAlD
Adenosine monophosphate—PYGL—brain—multiple sclerosis	0.000351	0.0104	CbGeAlD
Adenosine monophosphate—ACSL1—midbrain—multiple sclerosis	0.000351	0.0103	CbGeAlD
Adenosine monophosphate—HINT1—central nervous system—multiple sclerosis	0.000351	0.0103	CbGeAlD
Adenosine monophosphate—PIM1—spinal cord—multiple sclerosis	0.000349	0.0103	CbGeAlD
Adenosine monophosphate—ADK—retina—multiple sclerosis	0.000349	0.0103	CbGeAlD
Adenosine monophosphate—ACSS2—spinal cord—multiple sclerosis	0.000344	0.0102	CbGeAlD
Adenosine monophosphate—APRT—spinal cord—multiple sclerosis	0.000344	0.0102	CbGeAlD
Adenosine monophosphate—ADCY1—brain—multiple sclerosis	0.000344	0.0102	CbGeAlD
Adenosine monophosphate—HINT1—cerebellum—multiple sclerosis	0.000343	0.0101	CbGeAlD
Adenosine monophosphate—ACSL1—spinal cord—multiple sclerosis	0.000342	0.0101	CbGeAlD
Adenosine monophosphate—CREB1—midbrain—multiple sclerosis	0.000332	0.00979	CbGeAlD
Adenosine monophosphate—CREB1—spinal cord—multiple sclerosis	0.000324	0.00955	CbGeAlD
Adenosine monophosphate—PRKAB1—nervous system—multiple sclerosis	0.000312	0.00921	CbGeAlD
Adenosine monophosphate—ACSS1—nervous system—multiple sclerosis	0.000303	0.00893	CbGeAlD
Adenosine monophosphate—PRKAB1—central nervous system—multiple sclerosis	0.0003	0.00886	CbGeAlD
Adenosine monophosphate—PIM1—nervous system—multiple sclerosis	0.000294	0.00867	CbGeAlD
Adenosine monophosphate—PRKAB1—cerebellum—multiple sclerosis	0.000294	0.00866	CbGeAlD
Adenosine monophosphate—ACSS1—central nervous system—multiple sclerosis	0.000291	0.00859	CbGeAlD
Adenosine monophosphate—APRT—nervous system—multiple sclerosis	0.00029	0.00856	CbGeAlD
Adenosine monophosphate—ACSS2—nervous system—multiple sclerosis	0.00029	0.00856	CbGeAlD
Adenosine monophosphate—ACSL1—nervous system—multiple sclerosis	0.000288	0.0085	CbGeAlD
Adenosine monophosphate—ACSS1—cerebellum—multiple sclerosis	0.000285	0.0084	CbGeAlD
Adenosine monophosphate—PIM1—central nervous system—multiple sclerosis	0.000283	0.00835	CbGeAlD
Adenosine monophosphate—ACSS2—central nervous system—multiple sclerosis	0.000279	0.00824	CbGeAlD
Adenosine monophosphate—APRT—central nervous system—multiple sclerosis	0.000279	0.00824	CbGeAlD
Adenosine monophosphate—HINT1—brain—multiple sclerosis	0.000278	0.00821	CbGeAlD
Adenosine monophosphate—ACSL1—central nervous system—multiple sclerosis	0.000277	0.00819	CbGeAlD
Adenosine monophosphate—PIM1—cerebellum—multiple sclerosis	0.000277	0.00816	CbGeAlD
Adenosine monophosphate—Cladribine—RRM1—multiple sclerosis	0.000274	0.118	CrCbGaD
Adenosine monophosphate—APRT—cerebellum—multiple sclerosis	0.000273	0.00805	CbGeAlD
Adenosine monophosphate—ACSS2—cerebellum—multiple sclerosis	0.000273	0.00805	CbGeAlD
Adenosine monophosphate—CREB1—nervous system—multiple sclerosis	0.000273	0.00805	CbGeAlD
Adenosine monophosphate—PRKAA1—nervous system—multiple sclerosis	0.000273	0.00805	CbGeAlD
Adenosine monophosphate—ACSL1—cerebellum—multiple sclerosis	0.000271	0.008	CbGeAlD
Adenosine monophosphate—PRKAA1—central nervous system—multiple sclerosis	0.000263	0.00775	CbGeAlD
Adenosine monophosphate—CREB1—central nervous system—multiple sclerosis	0.000263	0.00775	CbGeAlD
Adenosine monophosphate—CREB1—cerebellum—multiple sclerosis	0.000257	0.00757	CbGeAlD
Adenosine monophosphate—PRKAA1—cerebellum—multiple sclerosis	0.000257	0.00757	CbGeAlD
Adenosine monophosphate—ADK—medulla oblongata—multiple sclerosis	0.000252	0.00744	CbGeAlD
Adenosine monophosphate—PDE4D—cerebellum—multiple sclerosis	0.00024	0.00709	CbGeAlD
Adenosine monophosphate—PRKAB1—brain—multiple sclerosis	0.000239	0.00704	CbGeAlD
Adenosine monophosphate—ACSS1—brain—multiple sclerosis	0.000231	0.00682	CbGeAlD
Adenosine monophosphate—ADK—midbrain—multiple sclerosis	0.000231	0.0068	CbGeAlD
Adenosine monophosphate—SRC—spinal cord—multiple sclerosis	0.000228	0.00673	CbGeAlD
Adenosine monophosphate—ADK—spinal cord—multiple sclerosis	0.000225	0.00663	CbGeAlD
Adenosine monophosphate—PIM1—brain—multiple sclerosis	0.000225	0.00663	CbGeAlD
Adenosine monophosphate—ACSS2—brain—multiple sclerosis	0.000222	0.00654	CbGeAlD
Adenosine monophosphate—APRT—brain—multiple sclerosis	0.000222	0.00654	CbGeAlD
Adenosine monophosphate—ACSL1—brain—multiple sclerosis	0.00022	0.0065	CbGeAlD
Adenosine monophosphate—PRKAA1—brain—multiple sclerosis	0.000209	0.00615	CbGeAlD
Adenosine monophosphate—CREB1—brain—multiple sclerosis	0.000209	0.00615	CbGeAlD
Adenosine monophosphate—PDE4D—brain—multiple sclerosis	0.000195	0.00576	CbGeAlD
Adenosine monophosphate—SRC—nervous system—multiple sclerosis	0.000192	0.00567	CbGeAlD
Adenosine monophosphate—ADK—nervous system—multiple sclerosis	0.00019	0.00559	CbGeAlD
Adenosine monophosphate—SRC—central nervous system—multiple sclerosis	0.000185	0.00546	CbGeAlD
Adenosine monophosphate—ADK—central nervous system—multiple sclerosis	0.000182	0.00538	CbGeAlD
Adenosine monophosphate—SRC—cerebellum—multiple sclerosis	0.000181	0.00533	CbGeAlD
Adenosine monophosphate—PDE4B—medulla oblongata—multiple sclerosis	0.000179	0.00529	CbGeAlD
Adenosine monophosphate—ADK—cerebellum—multiple sclerosis	0.000178	0.00526	CbGeAlD
Adenosine monophosphate—PDE4B—midbrain—multiple sclerosis	0.000164	0.00484	CbGeAlD
Adenosine monophosphate—PDE4B—spinal cord—multiple sclerosis	0.00016	0.00472	CbGeAlD
Adenosine monophosphate—SRC—brain—multiple sclerosis	0.000147	0.00433	CbGeAlD
Adenosine monophosphate—ADK—brain—multiple sclerosis	0.000145	0.00427	CbGeAlD
Adenosine monophosphate—PDE4B—nervous system—multiple sclerosis	0.000135	0.00398	CbGeAlD
Adenosine monophosphate—PDE4B—central nervous system—multiple sclerosis	0.00013	0.00383	CbGeAlD
Adenosine monophosphate—PDE4B—cerebellum—multiple sclerosis	0.000127	0.00374	CbGeAlD
Adenosine monophosphate—PDE4B—brain—multiple sclerosis	0.000103	0.00304	CbGeAlD
Adenosine monophosphate—PDE4D—Signaling Pathways—IL2RA—multiple sclerosis	4.94e-06	9.83e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling by GPCR—IL2—multiple sclerosis	4.9e-06	9.75e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CCL5—multiple sclerosis	4.9e-06	9.75e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CXCL13—multiple sclerosis	4.88e-06	9.71e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CCR1—multiple sclerosis	4.88e-06	9.71e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—IL2—multiple sclerosis	4.87e-06	9.69e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—PTPRC—multiple sclerosis	4.86e-06	9.68e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CCR2—multiple sclerosis	4.86e-06	9.68e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—HLA-A—multiple sclerosis	4.81e-06	9.58e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—TYK2—multiple sclerosis	4.81e-06	9.58e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—TLR4—multiple sclerosis	4.79e-06	9.54e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—APOE—multiple sclerosis	4.78e-06	9.51e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—SPP1—multiple sclerosis	4.77e-06	9.49e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—TLR4—multiple sclerosis	4.77e-06	9.49e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—HLA-DRB1—multiple sclerosis	4.76e-06	9.48e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—GPCR downstream signaling—IL2—multiple sclerosis	4.75e-06	9.46e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by FGFR in disease—IL6—multiple sclerosis	4.7e-06	9.36e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—HLA-DPB1—multiple sclerosis	4.7e-06	9.35e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Developmental Biology—TGFB1—multiple sclerosis	4.69e-06	9.33e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Axon guidance—MMP9—multiple sclerosis	4.67e-06	9.29e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—IFNG—multiple sclerosis	4.67e-06	9.29e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by EGFR—IL6—multiple sclerosis	4.66e-06	9.28e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—CCR5—multiple sclerosis	4.64e-06	9.23e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by EGFR in Cancer—IL6—multiple sclerosis	4.62e-06	9.19e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—MMP9—multiple sclerosis	4.61e-06	9.17e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—TYK2—multiple sclerosis	4.6e-06	9.16e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—HLA-DRB1—multiple sclerosis	4.6e-06	9.15e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by PDGF—IL6—multiple sclerosis	4.6e-06	9.15e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Developmental Biology—MAPK1—multiple sclerosis	4.6e-06	9.15e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by NGF—STAT3—multiple sclerosis	4.59e-06	9.13e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—POMC—multiple sclerosis	4.58e-06	9.11e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CD28—multiple sclerosis	4.57e-06	9.1e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—IL2RA—multiple sclerosis	4.57e-06	9.1e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—ICAM1—multiple sclerosis	4.57e-06	9.1e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—APOE—multiple sclerosis	4.56e-06	9.07e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling by GPCR—IL2—multiple sclerosis	4.54e-06	9.03e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—SPP1—multiple sclerosis	4.54e-06	9.03e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CD40—multiple sclerosis	4.52e-06	9e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—ITGA4—multiple sclerosis	4.52e-06	9e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—CD4—multiple sclerosis	4.51e-06	8.97e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—APOE—multiple sclerosis	4.49e-06	8.94e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IFNB1—multiple sclerosis	4.49e-06	8.93e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—CCL2—multiple sclerosis	4.48e-06	8.91e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CXCL10—multiple sclerosis	4.46e-06	8.88e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CTLA4—multiple sclerosis	4.46e-06	8.87e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—CD80—multiple sclerosis	4.43e-06	8.81e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—ICAM1—multiple sclerosis	4.41e-06	8.79e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CCR5—multiple sclerosis	4.41e-06	8.78e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—CD80—multiple sclerosis	4.4e-06	8.76e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Developmental Biology—TNF—multiple sclerosis	4.38e-06	8.71e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—IL2RA—multiple sclerosis	4.35e-06	8.66e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—POMC—multiple sclerosis	4.34e-06	8.63e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—CD80—multiple sclerosis	4.32e-06	8.6e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—IL2—multiple sclerosis	4.32e-06	8.59e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—ALB—multiple sclerosis	4.26e-06	8.48e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—CD80—multiple sclerosis	4.25e-06	8.46e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—TYK2—multiple sclerosis	4.23e-06	8.42e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—APOE—multiple sclerosis	4.22e-06	8.4e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Innate Immune System—IL6—multiple sclerosis	4.18e-06	8.33e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by NGF—MAPK1—multiple sclerosis	4.17e-06	8.3e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	4.16e-06	8.29e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—IL1B—multiple sclerosis	4.16e-06	8.28e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—CD4—multiple sclerosis	4.16e-06	8.28e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—IL2—multiple sclerosis	4.15e-06	8.25e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—CD80—multiple sclerosis	4.12e-06	8.2e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—POMC—multiple sclerosis	4.1e-06	8.17e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—STAT3—multiple sclerosis	4.1e-06	8.15e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—TYK2—multiple sclerosis	4.07e-06	8.09e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—CD80—multiple sclerosis	4.06e-06	8.09e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Innate Immune System—MAPK1—multiple sclerosis	4.06e-06	8.08e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—CCL2—multiple sclerosis	4.02e-06	7.99e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—APOE—multiple sclerosis	4.01e-06	7.99e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—IL2—multiple sclerosis	4e-06	7.97e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—ALB—multiple sclerosis	3.95e-06	7.87e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—VCAM1—multiple sclerosis	3.93e-06	7.83e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—HLA-DQA1—multiple sclerosis	3.92e-06	7.81e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—POMC—multiple sclerosis	3.92e-06	7.79e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CD86—multiple sclerosis	3.9e-06	7.76e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CCL5—multiple sclerosis	3.84e-06	7.64e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—CCL2—multiple sclerosis	3.83e-06	7.63e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—CD80—multiple sclerosis	3.82e-06	7.59e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—MYC—multiple sclerosis	3.81e-06	7.58e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—TGFB1—multiple sclerosis	3.8e-06	7.56e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—MMP9—multiple sclerosis	3.79e-06	7.54e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Axon guidance—MAPK1—multiple sclerosis	3.77e-06	7.51e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling by GPCR—MAPK1—multiple sclerosis	3.75e-06	7.46e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—TYK2—multiple sclerosis	3.74e-06	7.44e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—MAPK1—multiple sclerosis	3.72e-06	7.41e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—TYK2—multiple sclerosis	3.71e-06	7.39e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—HLA-DQB1—multiple sclerosis	3.67e-06	7.3e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—TYK2—multiple sclerosis	3.65e-06	7.26e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CD80—multiple sclerosis	3.63e-06	7.22e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—POMC—multiple sclerosis	3.63e-06	7.22e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—SPP1—multiple sclerosis	3.56e-06	7.08e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—CCL2—multiple sclerosis	3.55e-06	7.06e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CD86—multiple sclerosis	3.53e-06	7.03e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Developmental Biology—IL6—multiple sclerosis	3.53e-06	7.03e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—STAT3—multiple sclerosis	3.49e-06	6.94e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—TYK2—multiple sclerosis	3.48e-06	6.92e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—IFNG—multiple sclerosis	3.48e-06	6.92e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CCL3—multiple sclerosis	3.48e-06	6.92e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling by GPCR—MAPK1—multiple sclerosis	3.47e-06	6.91e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CD40LG—multiple sclerosis	3.46e-06	6.9e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CCR5—multiple sclerosis	3.46e-06	6.88e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—IL2—multiple sclerosis	3.45e-06	6.87e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—POMC—multiple sclerosis	3.45e-06	6.86e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—TYK2—multiple sclerosis	3.43e-06	6.83e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CD8A—multiple sclerosis	3.43e-06	6.82e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—IL2RA—multiple sclerosis	3.41e-06	6.78e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—IL2—multiple sclerosis	3.38e-06	6.73e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—CD4—multiple sclerosis	3.38e-06	6.72e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CCL2—multiple sclerosis	3.37e-06	6.72e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—STAT3—multiple sclerosis	3.37e-06	6.71e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—CD4—multiple sclerosis	3.36e-06	6.69e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PTGER4—multiple sclerosis	3.35e-06	6.66e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—MMP9—multiple sclerosis	3.33e-06	6.63e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—MAPK1—multiple sclerosis	3.3e-06	6.57e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—HLA-B—multiple sclerosis	3.3e-06	6.56e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PGR—multiple sclerosis	3.3e-06	6.56e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CD86—multiple sclerosis	3.26e-06	6.49e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—CD4—multiple sclerosis	3.24e-06	6.46e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CXCR3—multiple sclerosis	3.23e-06	6.43e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—TYK2—multiple sclerosis	3.22e-06	6.41e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—STAT3—multiple sclerosis	3.22e-06	6.41e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by NGF—IL6—multiple sclerosis	3.2e-06	6.38e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CD28—multiple sclerosis	3.2e-06	6.37e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—MAPK1—multiple sclerosis	3.17e-06	6.31e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—APOE—multiple sclerosis	3.15e-06	6.26e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CCR2—multiple sclerosis	3.14e-06	6.26e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—MYC—multiple sclerosis	3.13e-06	6.23e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—TGFB1—multiple sclerosis	3.12e-06	6.22e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Innate Immune System—IL6—multiple sclerosis	3.12e-06	6.21e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—IL1B—multiple sclerosis	3.1e-06	6.18e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—CD4—multiple sclerosis	3.1e-06	6.17e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—IL2—multiple sclerosis	3.09e-06	6.15e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IL2RA—multiple sclerosis	3.09e-06	6.15e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—TYK2—multiple sclerosis	3.06e-06	6.1e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—MAPK1—multiple sclerosis	3.06e-06	6.1e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—HLA-A—multiple sclerosis	3.05e-06	6.08e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—IL2—multiple sclerosis	3.03e-06	6.04e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—MYC—multiple sclerosis	2.99e-06	5.96e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—TGFB1—multiple sclerosis	2.99e-06	5.94e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—STAT3—multiple sclerosis	2.96e-06	5.9e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—MAPK1—multiple sclerosis	2.93e-06	5.83e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CNR1—multiple sclerosis	2.9e-06	5.78e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Axon guidance—IL6—multiple sclerosis	2.9e-06	5.77e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—IL2—multiple sclerosis	2.89e-06	5.76e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CCR5—multiple sclerosis	2.89e-06	5.76e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling by GPCR—IL6—multiple sclerosis	2.88e-06	5.73e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—MMP9—multiple sclerosis	2.87e-06	5.72e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—IL6—multiple sclerosis	2.86e-06	5.69e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CD80—multiple sclerosis	2.84e-06	5.66e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—HLA-A—multiple sclerosis	2.82e-06	5.61e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—TLR4—multiple sclerosis	2.79e-06	5.56e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—HLA-DRB1—multiple sclerosis	2.79e-06	5.55e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—TGFB1—multiple sclerosis	2.75e-06	5.46e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—MMP9—multiple sclerosis	2.74e-06	5.45e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—POMC—multiple sclerosis	2.7e-06	5.38e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—TGFB1—multiple sclerosis	2.69e-06	5.36e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—MAPK1—multiple sclerosis	2.69e-06	5.36e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—IL2—multiple sclerosis	2.68e-06	5.33e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—ICAM1—multiple sclerosis	2.68e-06	5.33e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling by GPCR—IL6—multiple sclerosis	2.67e-06	5.31e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CCL2—multiple sclerosis	2.64e-06	5.26e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—MAPK1—multiple sclerosis	2.64e-06	5.26e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—APOE—multiple sclerosis	2.63e-06	5.24e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CXCL10—multiple sclerosis	2.61e-06	5.2e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—STAT3—multiple sclerosis	2.6e-06	5.18e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—MAPK1—multiple sclerosis	2.59e-06	5.15e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CD80—multiple sclerosis	2.58e-06	5.13e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—TNF—multiple sclerosis	2.56e-06	5.1e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—STAT3—multiple sclerosis	2.55e-06	5.08e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—IL2—multiple sclerosis	2.55e-06	5.07e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—MMP9—multiple sclerosis	2.54e-06	5.05e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—IL6—multiple sclerosis	2.54e-06	5.05e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—IL6—multiple sclerosis	2.44e-06	4.85e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—STAT3—multiple sclerosis	2.44e-06	4.85e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—MMP9—multiple sclerosis	2.41e-06	4.8e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—TYK2—multiple sclerosis	2.4e-06	4.78e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—STAT3—multiple sclerosis	2.4e-06	4.78e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CD80—multiple sclerosis	2.38e-06	4.74e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—MAPK1—multiple sclerosis	2.38e-06	4.73e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—MYC—multiple sclerosis	2.37e-06	4.72e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—TGFB1—multiple sclerosis	2.37e-06	4.71e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—MAPK1—multiple sclerosis	2.36e-06	4.71e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—IL6—multiple sclerosis	2.35e-06	4.68e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—MAPK1—multiple sclerosis	2.32e-06	4.62e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CD86—multiple sclerosis	2.28e-06	4.55e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—MYC—multiple sclerosis	2.26e-06	4.51e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—TGFB1—multiple sclerosis	2.26e-06	4.49e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—STAT3—multiple sclerosis	2.26e-06	4.49e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—IL6—multiple sclerosis	2.25e-06	4.48e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CCL5—multiple sclerosis	2.25e-06	4.48e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—MYC—multiple sclerosis	2.23e-06	4.44e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—TGFB1—multiple sclerosis	2.23e-06	4.43e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—MAPK1—multiple sclerosis	2.21e-06	4.41e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—MAPK1—multiple sclerosis	2.18e-06	4.34e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—TYK2—multiple sclerosis	2.18e-06	4.33e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—STAT3—multiple sclerosis	2.15e-06	4.27e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—MYC—multiple sclerosis	2.1e-06	4.17e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—TGFB1—multiple sclerosis	2.09e-06	4.16e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—SPP1—multiple sclerosis	2.08e-06	4.15e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—IL6—multiple sclerosis	2.07e-06	4.12e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—MAPK1—multiple sclerosis	2.05e-06	4.08e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IFNG—multiple sclerosis	2.04e-06	4.06e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CCR5—multiple sclerosis	2.03e-06	4.03e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—TYK2—multiple sclerosis	2.01e-06	4e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—IL2—multiple sclerosis	2e-06	3.98e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IL2RA—multiple sclerosis	2e-06	3.97e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—MYC—multiple sclerosis	1.99e-06	3.97e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—TGFB1—multiple sclerosis	1.99e-06	3.96e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—IL6—multiple sclerosis	1.99e-06	3.96e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CD4—multiple sclerosis	1.97e-06	3.92e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—MAPK1—multiple sclerosis	1.95e-06	3.88e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MMP9—multiple sclerosis	1.89e-06	3.76e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—APOE—multiple sclerosis	1.84e-06	3.67e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—IL6—multiple sclerosis	1.83e-06	3.64e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IL1B—multiple sclerosis	1.82e-06	3.62e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CD4—multiple sclerosis	1.82e-06	3.62e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—IL6—multiple sclerosis	1.82e-06	3.62e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IL2—multiple sclerosis	1.81e-06	3.6e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—IL6—multiple sclerosis	1.78e-06	3.55e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—IL6—multiple sclerosis	1.7e-06	3.39e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—STAT3—multiple sclerosis	1.68e-06	3.35e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—IL6—multiple sclerosis	1.68e-06	3.34e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CD80—multiple sclerosis	1.67e-06	3.32e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—POMC—multiple sclerosis	1.58e-06	3.15e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—IL6—multiple sclerosis	1.58e-06	3.14e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MYC—multiple sclerosis	1.56e-06	3.11e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—TGFB1—multiple sclerosis	1.56e-06	3.1e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CCL2—multiple sclerosis	1.55e-06	3.08e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MAPK1—multiple sclerosis	1.53e-06	3.04e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—STAT3—multiple sclerosis	1.52e-06	3.03e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—IL6—multiple sclerosis	1.5e-06	2.98e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—TYK2—multiple sclerosis	1.41e-06	2.8e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—STAT3—multiple sclerosis	1.41e-06	2.8e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—MAPK1—multiple sclerosis	1.38e-06	2.76e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—MYC—multiple sclerosis	1.31e-06	2.6e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—TGFB1—multiple sclerosis	1.3e-06	2.6e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—MAPK1—multiple sclerosis	1.28e-06	2.55e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—IL6—multiple sclerosis	1.17e-06	2.34e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IL2—multiple sclerosis	1.17e-06	2.33e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MMP9—multiple sclerosis	1.11e-06	2.21e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IL6—multiple sclerosis	1.06e-06	2.12e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—STAT3—multiple sclerosis	9.85e-07	1.96e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—IL6—multiple sclerosis	9.82e-07	1.96e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MYC—multiple sclerosis	9.15e-07	1.82e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—TGFB1—multiple sclerosis	9.13e-07	1.82e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MAPK1—multiple sclerosis	8.95e-07	1.78e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IL6—multiple sclerosis	6.88e-07	1.37e-05	CbGpPWpGaD
